Quarterly Consolidated Statement Of Cash Flows

Immuno-Biological Laboratories Co., Ltd. - Filing #7553802

Concept As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
35,588,000 JPY
-84,173,000 JPY
Interest and dividends received
288,000 JPY
125,000 JPY
Interest paid
-1,041,000 JPY
-730,000 JPY
Income taxes paid
-8,376,000 JPY
-8,425,000 JPY
Net cash provided by (used in) operating activities
26,458,000 JPY
-93,204,000 JPY
Cash flows from investing activities
Proceeds from sale of property, plant and equipment
JPY
371,000 JPY
Loan advances
JPY
-10,000,000 JPY
Other, net
1,250,000 JPY
JPY
Net cash provided by (used in) investing activities
30,036,000 JPY
-155,629,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
60,000,000 JPY
Repayments of long-term borrowings
-4,008,000 JPY
-21,002,000 JPY
Other, net
0 JPY
JPY
Net cash provided by (used in) financing activities
991,000 JPY
143,998,000 JPY
Effect of exchange rate change on cash and cash equivalents
2,084,000 JPY
1,998,000 JPY
Net increase (decrease) in cash and cash equivalents
59,571,000 JPY
-102,837,000 JPY
Cash and cash equivalents
561,997,000 JPY
449,184,000 JPY
552,022,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.